EU And US Could Do More Together In Areas Of Medtech Approvals And Inspections

The EU and US medtech regulatory systems remain divergent, resulting in double controls, but there is potential to do more in the areas of approvals and inspections.

That is the European Commission’s message, contained in a recent fact sheet that looks at “EU/US trade talks one year on: exploring trade opportunities." It is worth noting that...